64 research outputs found

    The Assessment of the Level of Pollution of Slime Pits with Heavy Metals

    Get PDF
    In drilling and running oil and gas wells the great amount of toxic waste is formed and in the surface of the lithosphere and hydrosphere the great amount of different chemical elements and compounds access, they are needed to be isolated from the environment. The most useful way of isolation is their utilization in the slime pits on the wells territory. Heavy metals are dangerous waste in the drilling slime; they accumulate in soil and under some conditions they in form water-soluble parts and migrate in to the soil. The aim of this paper is to organize the chemical and analytical research of the amount of heavy metals in the drilling slime, and research the mechanism of their spreading on different depth and square in the slime pits typical for the oil site placed in KHANTY-Ugra

    Determination of Safety Indicators in the Developed Muffins with Non-traditional Raw Materials

    Full text link
    The aim of research is studying the effect of unconventional raw materials (buckwheat, oatmeal, rye, corn, milk whey, skimmed milk powder, propolis, flower pollen, bean powder, sesame oil, pumpkin seed oil, walnut oil, walnut kernels, candied fruit mixes (apple-cherry fruits of bilberries, natural honey with floral pollen, natural honey with propolis) for the quality and safety of new muffins. The article analyzes the results of the study of the quality and safety indicators of muffins of improved composition, manufactured using non-traditional raw materials. For the preparation of new types of muffins, part of the wheat flour was replaced with buckwheat, corn, oat, milk whey, skimmed milk powder and additives of vegetable origin. Margarine has been replaced by vegetable oils. It has been established that flour confectionery products have high organoleptic properties. From the physico-chemical parameters, the mass fraction of total sugar was determined, which ranged from 28.17 % to 33.07 %, the mass fraction of fat – 16.2–20.66 %, the mass fraction of moisture – 18.0–22.0, mass fraction of ash – 0.03–1.3 %, alkalinity – 0.03–1.8°, the content of toxic elements (copper, zinc, lead, cadmium, arsenic, mercury) and microbiological indicators were also determined. Based on the data obtained as a research result, the expediency of using non-traditional raw materials to expand the range of flour confectionery products, in particular muffins is substantiated

    Geometric control of universal hydrodynamic flow in a two dimensional electron fluid

    Full text link
    Fluid dynamics is one of the cornerstones of modern physics and has recently found applications in the transport of electrons in solids. In most solids electron transport is dominated by extrinsic factors, such as sample geometry and scattering from impurities. However in the hydrodynamic regime Coulomb interactions transform the electron motion from independent particles to the collective motion of a viscous `electron fluid'. The fluid viscosity is an intrinsic property of the electron system, determined solely by the electron-electron interactions. Resolving the universal intrinsic viscosity is challenging, as it only affects the resistance through interactions with the sample boundaries, whose roughness is not only unknown but also varies from device to device. Here we eliminate all unknown parameters by fabricating samples with smooth sidewalls to achieve the perfect slip boundary condition, which has been elusive both in molecular fluids and electronic systems. We engineer the device geometry to create viscous dissipation and reveal the true intrinsic hydrodynamic properties of a 2D system. We observe a clear transition from ballistic to hydrodynamic electron motion, driven by both temperature and magnetic field. We directly measure the viscosity and electron-electron scattering lifetime (the Fermi quasiparticle lifetime) over a wide temperature range without fitting parameters, and show they have a strong dependence on electron density that cannot be explained by conventional theories based on the Random Phase Approximation

    Development of polyresistance in microorganisms during antibiotic therapy in a multidisciplinary hospital during a pandemic COVID-19

    Get PDF
    Background. Irrational and excessive use of antimicrobials drugs (AMD) creates conditions for the development of a global crisis of health systems around the world associated with antibiotic resistance. Aim. To conduct a retrospective study of the impact of the use of AMD on the change in the microbiological landscape and the sensitivity of microorganisms in the conditions of pandemic of the new coronavirus infection (COVID-19) in 2020–2021 in intensive care departments (ICD) of a multidisciplinary hospital. Materials and methods. In the course of the work, strains of microorganisms isolated from patients and from the surfaces of the hospital environment and changes in their sensitivity to significant groups of AMD in ICD for somatic and infectious patients with COVID-19 were compared. The sensitivity of the isolates was evaluated in accordance with the criteria of requirements of European Committee on Antimicrobial Susceptibility Testing – EUCAST, version 10.0, 2020. Results. A total of 1,394 isolates were studied, including 1,379 clinical and 15 isolates from the surfaces of the hospital environment. It was found that in all ICD in 2020–2021, gram-negative microorganisms prevailed in infectious loci in 70% of cases or more. In 2021, in the ICD in infectious patients with COVID-19, the persistent dominance of the Acinetobacter baumannii microorganism was revealed with an increase in the number of poly- and pan-resistant strains – 48.7%. While in the ICD for somatic patients Klebsiella Pneumoniae prevailed among gram-negative microorganisms – 37.5% in 2020 and 43.7% in 2021. It has been shown that in one department or in adjacent departments of the same medical institution, various nosocomial microorganisms with an unequal set of resistance genes and sensitivity to AMD may appear over time. Conclusion. The necessity of conducting constant microbiological monitoring and a passport of the medical department with mandatory registration of not only isolated strains of microorganisms, but also resistance genes in order to optimize the appointment of timely adequate empirical antimicrobial therapy is substantiated. The period of the latter should be as short as possible, and confirmed by convincing clinical signs of bacterial infection, and subsequently by the isolation of nosocomial flora from the biomaterial of critical loci from patients

    Critical implications of IVDR for innovation in diagnostics: input from the BioMed alliance diagnostics task force

    Get PDF
    With the implementation of Regulation (European Union [EU]) 2017/746 on in vitro diagnostic medical devices (IVDR), from May 26, 2022, onwards, the development and use of diagnostic tests will be governed by a vastly expanded and upgraded EU regulatory framework. We provide here an overview of the amended transition timelines, the role of notified bodies, EU reference laboratories, expert panels, and the Medical Device Coordination Group (MDCG). We also describe the implications of the IVDR for innovative laboratory medicine by explaining the exemption for in-house devices (IH-IVDs). Two key challenges faced by the academic diagnostic sector are: (1) the stipulation on equivalence of tests (article 5.5d), which poses a new condition for the use of IH-IVDs and (2) the gray area between CE marked in vitro diagnostics (CE-IVDs), modified CE-IVDs, Research Use Only (RUO) tests, and IH-IVDs. Furthermore, the results of a questionnaire on current diagnostic practice conducted by European medical societies collaborating in the BioMed Alliance indicate widespread use of IH-IVDs in diagnostic laboratories across Europe and emphasize the need for support and guidance to comply with the IVDR. Diagnostic equivalents of the European Reference Networks (ERNs) for rare diseases could help ensure affordable and equal access to specialized diagnostics across the EU. Concerted action by clinical and laboratory disciplines, regulators, industry, and patient organizations is needed to support the efficient and effective implementation of the IVDR in a way that preserves innovation and safeguards the quality, safety, and accessibility of innovative diagnostics.Peer reviewe

    Đ’Đ»ĐžŃĐœĐžĐ” ŃŃ‚Đ”ĐżĐ”ĐœĐž ĐŸĐșĐžŃĐ»Đ”ĐœĐžŃ Đž Ń€Đ°ŃĐżŃ€Đ”ĐŽĐ”Đ»Đ”ĐœĐžŃ частоц Ń€ŃƒŃ‚Đ”ĐœĐžŃ ĐœĐ° ĐłĐžĐŽŃ€ĐžŃ€ĐŸĐČĐ°ĐœĐžĐ” лДĐČŃƒĐ»ĐžĐœĐŸĐČĐŸĐč ĐșĐžŃĐ»ĐŸŃ‚Ń‹ ĐČ ĐżŃ€ĐžŃŃƒŃ‚ŃŃ‚ĐČОО Ru-ŃĐŸĐŽĐ”Ń€Đ¶Đ°Ń‰ĐžŃ… ĐșĐ°Ń‚Đ°Đ»ĐžĐ·Đ°Ń‚ĐŸŃ€ĐŸĐČ ĐœĐ° ĐŸŃĐœĐŸĐČĐ” Ń†Đ”ĐŸĐ»ĐžŃ‚ĐŸĐČ

    Get PDF
    The paper presents data on the synthesis of ruthenium catalysts based on the zeolites HBeta, H΄, HMordenite and HZSM‑5 and their testing in the hydrogenation reaction of levulinic acid to gamma- valerolactone in an aqueous medium at a temperature of 100 oC and partial hydrogen pressure of 1 MPa. For the initial zeolites and synthesized catalysts, physicochemical study was carried out using low- temperature nitrogen physisorption, XPS, DRIFT spectroscopy using CD3CN as a probe molecule, and electron microscopy. The dependence of the activity of Ru/zeolite composites on the surface content of RuO2 was establishedВ Ń€Đ°Đ±ĐŸŃ‚Đ” прДЎстаĐČĐ»Đ”ĐœŃ‹ ĐŽĐ°ĐœĐœŃ‹Đ” ĐżĐŸ ŃĐžĐœŃ‚Đ”Đ·Ńƒ Ń€ŃƒŃ‚Đ”ĐœĐžĐ”ĐČых ĐșĐ°Ń‚Đ°Đ»ĐžĐ·Đ°Ń‚ĐŸŃ€ĐŸĐČ ĐœĐ° ĐŸŃĐœĐŸĐČĐ” Ń†Đ”ĐŸĐ»ĐžŃ‚ĐŸĐČ HBeta, H΄, HMordenite Đž HZSM‑5 Đž ох Ń‚Đ”ŃŃ‚ĐžŃ€ĐŸĐČĐ°ĐœĐžŃŽ ĐČ Ń€Đ”Đ°Đșцоо ĐłĐžĐŽŃ€ĐžŃ€ĐŸĐČĐ°ĐœĐžŃ лДĐČŃƒĐ»ĐžĐœĐŸĐČĐŸĐč ĐșĐžŃĐ»ĐŸŃ‚Ń‹ ĐŽĐŸ ĐłĐ°ĐŒĐŒĐ°-ĐČĐ°Đ»Đ”Ń€ĐŸĐ»Đ°ĐșŃ‚ĐŸĐœĐ° ĐČ ĐČĐŸĐŽĐœĐŸĐč срДЎД про Ń‚Đ”ĐŒĐżĐ”Ń€Đ°Ń‚ŃƒŃ€Đ” 100 ĐŸ ĐĄ Đž ĐżĐ°Ń€Ń†ĐžĐ°Đ»ŃŒĐœĐŸĐŒ ĐŽĐ°ĐČĐ»Đ”ĐœĐžĐž ĐČĐŸĐŽĐŸŃ€ĐŸĐŽĐ° 1 МПа. Đ”Đ»Ń ĐžŃŃ…ĐŸĐŽĐœŃ‹Ń… Ń†Đ”ĐŸĐ»ĐžŃ‚ĐŸĐČ Đž ĐșĐ°Ń‚Đ°Đ»ĐžĐ·Đ°Ń‚ĐŸŃ€ĐŸĐČ ĐœĐ° ох ĐŸŃĐœĐŸĐČĐ” ĐżŃ€ĐŸĐČĐ”ĐŽĐ”ĐœĐŸ фОзОĐșĐŸ-Ń…ĐžĐŒĐžŃ‡Đ”ŃĐșĐŸĐ” ĐžŃŃĐ»Đ”ĐŽĐŸĐČĐ°ĐœĐžĐ” ĐŒĐ”Ń‚ĐŸĐŽĐ°ĐŒĐž ĐœĐžĐ·ĐșĐŸŃ‚Đ”ĐŒĐżĐ”Ń€Đ°Ń‚ŃƒŃ€ĐœĐŸĐč Đ°ĐŽŃĐŸŃ€Đ±Ń†ĐžĐž Đ°Đ·ĐŸŃ‚Đ°, РЀЭХ, Đ˜Đšâ€‘ŃĐżĐ”ĐșŃ‚Ń€ĐŸŃĐșĐŸĐżĐžĐž с Đ°ĐŽŃĐŸŃ€Đ±Ń†ĐžĐ”Đč CD3CN, Đ° таĐșжД ŃĐ»Đ”ĐșŃ‚Ń€ĐŸĐœĐœĐŸĐč ĐŒĐžĐșŃ€ĐŸŃĐșĐŸĐżĐžĐž. ĐŁŃŃ‚Đ°ĐœĐŸĐČĐ»Đ”ĐœĐ° Đ·Đ°ĐČĐžŃĐžĐŒĐŸŃŃ‚ŃŒ Đ°ĐșтоĐČĐœĐŸŃŃ‚Đž ĐșĐŸĐŒĐżĐŸĐ·ĐžŃ‚ĐŸĐČ Ru/Ń†Đ”ĐŸĐ»ĐžŃ‚ ĐŸŃ‚ ĐżĐŸĐČĐ”Ń€Ń…ĐœĐŸŃŃ‚ĐœĐŸĐłĐŸ ŃĐŸĐŽĐ”Ń€Đ¶Đ°ĐœĐžŃ RuO

    High frequency of BRCA1, but not CHEK2 or NBS1 (NBN), founder mutations in Russian ovarian cancer patients

    Get PDF
    <p>Abstract</p> <p>Background</p> <p>A significant portion of ovarian cancer (OC) cases is caused by germ-line mutations in BRCA1 or BRCA2 genes. BRCA testing is cheap in populations with founder effect and therefore recommended for all patients with OC diagnosis. Recurrent mutations constitute the vast majority of BRCA defects in Russia, however their impact in OC morbidity has not been yet systematically studied. Furthermore, Russian population is characterized by a relatively high frequency of CHEK2 and NBS1 (NBN) heterozygotes, but it remains unclear whether these two genes contribute to the OC risk.</p> <p>Methods</p> <p>The study included 354 OC patients from 2 distinct, geographically remote regions (290 from North-Western Russia (St.-Petersburg) and 64 from the south of the country (Krasnodar)). DNA samples were tested by allele-specific PCR for the presence of 8 founder mutations (BRCA1 5382insC, BRCA1 4153delA, BRCA1 185delAG, BRCA1 300T>G, BRCA2 6174delT, CHEK2 1100delC, CHEK2 IVS2+1G>A, NBS1 657del5). In addition, literature data on the occurrence of BRCA1, BRCA2, CHEK2 and NBS1 mutations in non-selected ovarian cancer patients were reviewed.</p> <p>Results</p> <p>BRCA1 5382insC allele was detected in 28/290 (9.7%) OC cases from the North-West and 11/64 (17.2%) OC patients from the South of Russia. In addition, 4 BRCA1 185delAG, 2 BRCA1 4153delA, 1 BRCA2 6174delT, 2 CHEK2 1100delC and 1 NBS1 657del5 mutation were detected. 1 patient from Krasnodar was heterozygous for both BRCA1 5382insC and NBS1 657del5 variants.</p> <p>Conclusion</p> <p>Founder BRCA1 mutations, especially BRCA1 5382insC variant, are responsible for substantial share of OC morbidity in Russia, therefore DNA testing has to be considered for every OC patient of Russian origin. Taken together with literature data, this study does not support the contribution of CHEK2 in OC risk, while the role of NBS1 heterozygosity may require further clarification.</p

    Final Targeting Strategy for the SDSS-IV APOGEE-2N Survey

    Full text link
    APOGEE-2 is a dual-hemisphere, near-infrared (NIR), spectroscopic survey with the goal of producing a chemo-dynamical mapping of the Milky Way Galaxy. The targeting for APOGEE-2 is complex and has evolved with time. In this paper, we present the updates and additions to the initial targeting strategy for APOGEE-2N presented in Zasowski et al. (2017). These modifications come in two implementation modes: (i) "Ancillary Science Programs" competitively awarded to SDSS-IV PIs through proposal calls in 2015 and 2017 for the pursuit of new scientific avenues outside the main survey, and (ii) an effective 1.5-year expansion of the survey, known as the Bright Time Extension, made possible through accrued efficiency gains over the first years of the APOGEE-2N project. For the 23 distinct ancillary programs, we provide descriptions of the scientific aims, target selection, and how to identify these targets within the APOGEE-2 sample. The Bright Time Extension permitted changes to the main survey strategy, the inclusion of new programs in response to scientific discoveries or to exploit major new datasets not available at the outset of the survey design, and expansions of existing programs to enhance their scientific success and reach. After describing the motivations, implementation, and assessment of these programs, we also leave a summary of lessons learned from nearly a decade of APOGEE-1 and APOGEE-2 survey operations. A companion paper, Santana et al. (submitted), provides a complementary presentation of targeting modifications relevant to APOGEE-2 operations in the Southern Hemisphere.Comment: 59 pages; 11 Figures; 7 Tables; 2 Appendices; Submitted to Journal and Under Review; Posting to accompany papers using the SDSS-IV/APOGEE-2 Data Release 17 scheduled for December 202

    2018 Research & Innovation Day Program

    Get PDF
    A one day showcase of applied research, social innovation, scholarship projects and activities.https://first.fanshawec.ca/cri_cripublications/1005/thumbnail.jp

    The Seventeenth Data Release of the Sloan Digital Sky Surveys: Complete Release of MaNGA, MaStar and APOGEE-2 Data

    Get PDF
    This paper documents the seventeenth data release (DR17) from the Sloan Digital Sky Surveys; the fifth and final release from the fourth phase (SDSS-IV). DR17 contains the complete release of the Mapping Nearby Galaxies at Apache Point Observatory (MaNGA) survey, which reached its goal of surveying over 10,000 nearby galaxies. The complete release of the MaNGA Stellar Library (MaStar) accompanies this data, providing observations of almost 30,000 stars through the MaNGA instrument during bright time. DR17 also contains the complete release of the Apache Point Observatory Galactic Evolution Experiment 2 (APOGEE-2) survey which publicly releases infra-red spectra of over 650,000 stars. The main sample from the Extended Baryon Oscillation Spectroscopic Survey (eBOSS), as well as the sub-survey Time Domain Spectroscopic Survey (TDSS) data were fully released in DR16. New single-fiber optical spectroscopy released in DR17 is from the SPectroscipic IDentification of ERosita Survey (SPIDERS) sub-survey and the eBOSS-RM program. Along with the primary data sets, DR17 includes 25 new or updated Value Added Catalogs (VACs). This paper concludes the release of SDSS-IV survey data. SDSS continues into its fifth phase with observations already underway for the Milky Way Mapper (MWM), Local Volume Mapper (LVM) and Black Hole Mapper (BHM) surveys
    • 

    corecore